Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 2—February 2006
Perspective

HIV Drug-resistant Strains as Epidemiologic Sentinels

María S. Sánchez*Comments to Author , Robert M. Grant†, Travis C. Porco‡, and Wayne M. Getz*
Author affiliations: *University of California, Berkeley, California, USA; †Gladstone Institute of Virology and Immunology, San Francisco, California, USA; ‡California Department of Health Services, Berkeley, California, USA

Main Article

Table

Impact of an increase in high-risk behavior, decrease in the fraction of acute HIV infected persons receiving treatment, and increase in treatment efficacy on the primary resistant fraction, disease, and resistance prevalence in the overall population

Cause Effect
Primary resistant fraction Disease prevalence Resistance prevalence
Increase in high-risk behavior Temporary decrease Permanent increase Permanent increase
Decrease in fraction acute treated Permanent decrease Permanent increase Permanent decrease
Increase in treatment efficacy Permanent decrease Permanent decrease Permanent decrease

Main Article

Page created: February 02, 2012
Page updated: February 02, 2012
Page reviewed: February 02, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external